Ledger.Open graph →

SEC Form D · filed January 24, 2025

Tune Therapeutics, Inc

Offering

$208.0M

Sold

$182.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Derek Jantz · DURHAM, NCExec Ali Behbahani · South San Francisco, CADirector Dan Mchugh · Atlanta, GAExec · Director Akira Matsuno · Seattle, WAExec Blythe Sather · Seattle, WAExec Charles Gersbach · Seattle, WADirector John Mchutchison · Seattle, WADirector Yuan Zhang · Chicago, ILExec Zachary Hale · Seattle, WAExec Ali Behbahani · Timonium, MDDirector Dan Mchugh · Atlanta, GAExec · Director Akira Matsuno · Seattle, WAExec Blythe Sather · Seattle, WAExec Derek Jantz · DURHAM, NCExec Charles Gersbach · Seattle, WADirector John Mchutchison · Seattle, WADirector Yuan Zhang · Chicago, ILExec Zachary Hale · Seattle, WAExec Ali Behbahani · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗